(Nitroglycerin Sublingual Powder)
The FDA recently approved GoNitro™ (nitroglycerin) sublingual powder, the first and only short-acting nitrate in a stabilized crystal granule form available in single dose packets.
Important Safety Information
GoNitro™ (nitroglycerin) sublingual powder should not be used if you are taking medications for erectile dysfunction, such as avanafil, sildenafil, tadalafil, or vardenafil. Using GoNitro with these products may cause low blood pressure (hypotension), fainting, or heart attack.
Do not use GoNitro if you are taking soluble guanylate cyclase (sGC) stimulators, such as riociguat. Using GoNitro with these products may cause low blood pressure (hypotension).
GoNitro should not be used if you have anemia.
GoNitro should not be used in patients with increased intracranial pressure. Talk to your doctor if you had a cerebral hemorrhage or traumatic brain injury before taking GoNitro.
GoNitro should not be used if you have acute circulatory failure or shock.
GoNitro should not be used if you are allergic to nitroglycerin, other nitrates or nitrites or any excipient.
You might develop a tolerance to this drug or to other nitrates and nitrites. Only the smallest number of doses required for effective relief of the acute angina attack or prevention of an attack should be used.
You should use nitroglycerin with caution in the early days after a heart attack and it may aggravate the angina caused by a condition known as hypertrophic cardiomyopathy. Increased hypotension, mainly when standing upright, may occur even with small doses of nitroglycerin and may result in slow heart beat and increased angina. It should be used with caution if you are dehydrated due to drug therapy or if you have low blood pressure.
Headache is the most reported side effect and may be severe and persistent. Other side effects that have been reported are dizziness, numbness and tingling of the skin, skin scaling and rashes, drowsiness, nausea, increased heart rate.
Click here for full Prescribing Information.